BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35945907)

  • 1. Comparison of a multitarget blood test to ultrasound and alpha-fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta-analysis.
    Singal AG; Haaland B; Parikh ND; Ozbay AB; Kirshner C; Chakankar S; Porter K; Chhatwal J; Ayer T
    Hepatol Commun; 2022 Oct; 6(10):2925-2936. PubMed ID: 35945907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma.
    Chalasani NP; Porter K; Bhattacharya A; Book AJ; Neis BM; Xiong KM; Ramasubramanian TS; Edwards DK; Chen I; Johnson S; Roberts LR; Kisiel JB; Reddy KR; Singal AG; Olson MC; Bruinsma JJ
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):173-182.e7. PubMed ID: 34391922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study.
    Chhatwal J; Samur S; Yang JD; Roberts LR; Nguyen MH; Ozbay AB; Ayer T; Parikh ND; Singal AG
    Hepatol Commun; 2023 Jun; 7(6):. PubMed ID: 37204402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
    Tzartzeva K; Obi J; Rich NE; Parikh ND; Marrero JA; Yopp A; Waljee AK; Singal AG
    Gastroenterology; 2018 May; 154(6):1706-1718.e1. PubMed ID: 29425931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
    Colli A; Nadarevic T; Miletic D; Giljaca V; Fraquelli M; Štimac D; Casazza G
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013346. PubMed ID: 33855699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
    Worland T; Harrison B; Delmenico L; Dowling D
    J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System.
    Tayob N; Richardson P; White DL; Yu X; Davila JA; Kanwal F; Feng Z; El-Serag HB
    BMC Med Res Methodol; 2018 Jan; 18(1):1. PubMed ID: 29301497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis.
    Kim MN; Kim BK; Kim SU; Park JY; Ahn SH; Han KH; Kim DY
    Scand J Gastroenterol; 2019 Oct; 54(10):1283-1290. PubMed ID: 31593481
    [No Abstract]   [Full Text] [Related]  

  • 9. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Chang TS; Wu YC; Tung SY; Wei KL; Hsieh YY; Huang HC; Chen WM; Shen CH; Lu CH; Wu CS; Tsai YH; Huang YH
    Am J Gastroenterol; 2015 Jun; 110(6):836-44; quiz 845. PubMed ID: 25869392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
    Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K
    Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.
    Huang TS; Shyu YC; Turner R; Chen HY; Chen PJ
    Syst Rev; 2013 Jun; 2():37. PubMed ID: 23738605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
    Zhang J; Chen G; Zhang P; Zhang J; Li X; Gan D; Cao X; Han M; Du H; Ye Y
    PLoS One; 2020; 15(2):e0228857. PubMed ID: 32053643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.
    Singal A; Volk ML; Waljee A; Salgia R; Higgins P; Rogers MA; Marrero JA
    Aliment Pharmacol Ther; 2009 Jul; 30(1):37-47. PubMed ID: 19392863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-Based Cohort of Patients With Cirrhosis of Multiple Etiologies.
    Tayob N; Corley DA; Christie I; Almers L; Rahal AK; Richardson P; White DL; Davila J; Kanwal F; El-Serag HB
    Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1443-1450.e6. PubMed ID: 32768590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical validation of a novel multi-target blood-based test to detect hepatocellular carcinoma.
    Johnson AM; Dudek JM; Edwards DK; Myers TA; Joseph P; Laffin JJ; Bruinsma JJ
    Expert Rev Mol Diagn; 2021 Nov; 21(11):1245-1252. PubMed ID: 34581651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis.
    Daher D; Seif El Dahan K; Cano A; Gonzales M; Ransom C; Jaurez E; Carranza O; Quirk L; Morgan T; Gopal P; Patel MS; Lieber S; Louissaint J; Cotter TG; VanWagner LB; Yang JD; Parikh ND; Yopp A; Rich NE; Singal AG
    Clin Gastroenterol Hepatol; 2024 Feb; 22(2):295-304.e2. PubMed ID: 37573986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis.
    Singal AG; Conjeevaram HS; Volk ML; Fu S; Fontana RJ; Askari F; Su GL; Lok AS; Marrero JA
    Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):793-9. PubMed ID: 22374994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma.
    Chalasani NP; Ramasubramanian TS; Bhattacharya A; Olson MC; Edwards V DK; Roberts LR; Kisiel JB; Reddy KR; Lidgard GP; Johnson SC; Bruinsma JJ
    Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2597-2605.e4. PubMed ID: 32889146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AFP-L3 for the diagnosis of early hepatocellular carcinoma: A meta-analysis.
    Zhou JM; Wang T; Zhang KH
    Medicine (Baltimore); 2021 Oct; 100(43):e27673. PubMed ID: 34713864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis.
    Biselli M; Conti F; Gramenzi A; Frigerio M; Cucchetti A; Fatti G; D'Angelo M; Dall'Agata M; Giannini EG; Farinati F; Ciccarese F; Andreone P; Bernardi M; Trevisani F
    Br J Cancer; 2015 Jan; 112(1):69-76. PubMed ID: 25314061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.